Hunting Hill Global Capital, LLC - COEPTIS THERAPEUTICS HLDGS I ownership

Back to all holdings Add to watchlist

COEPTIS THERAPEUTICS HLDGS I's ticker is and the CUSIP is 19207A116. A total of 22 filers reported holding COEPTIS THERAPEUTICS HLDGS I in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Hunting Hill Global Capital, LLC ownership history of COEPTIS THERAPEUTICS HLDGS I
ValueSharesWeighting
Q3 2023$370
-68.5%
16,3820.0%0.00%–
Q2 2023$1,175
-51.3%
16,3820.0%0.00%
-100.0%
Q1 2023$2,411
+47.3%
16,3820.0%0.00%
+100.0%
Q4 2022$1,637–16,382–0.00%–
 Download
Other shareholders
COEPTIS THERAPEUTICS HLDGS I shareholders Q4 2022
NameSharesValueWeighting ↓
Ionic Capital Management LLC 418,728$41,8310.01%
METEORA CAPITAL, LLC 291,933$29,1640.01%
Kepos Capital LP 250,000$250.00%
Radcliffe Capital Management, L.P. 37,500$57,4240.00%
SkyView Investment Advisors, LLC 55,122$60.00%
Hunting Hill Global Capital, LLC 16,382$1,6370.00%
RIVERNORTH CAPITAL MANAGEMENT, LLC 150,000$15,0000.00%
CSS LLC/IL 73,748$14,7340.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Virtu Financial LLC 20,693$20.00%
View complete list of COEPTIS THERAPEUTICS HLDGS I shareholders